AL
JAZZ icon

AJO LP’s Jazz Pharmaceuticals JAZZ Stock Holding History

AJO LP’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,833
Closed -$632K – 150
2020
Q4 		$632K Sell
3,833
-188,502
-98% -$28.1M 0.07% 200
2020
Q3 		$27.4M Sell
192,335
-128,794
-40% -$16M 0.29% 101
2020
Q2 		$35.4M Sell
321,129
-65,588
-17% -$7.25M 0.32% 90
2020
Q1 		$38.6M Sell
386,717
-76,770
-17% -$9.93M 0.35% 91
2019
Q4 		$69.2M Buy
463,487
+150,763
+48% +$20.5M 0.41% 84
2019
Q3 		$40.1M Sell
312,724
-26,887
-8% -$3.6M 0.23% 122
2019
Q2 		$48.4M Buy
339,611
+11,245
+3% +$1.51M 0.25% 121
2019
Q1 		$46.9M Buy
328,366
+153,623
+88% +$20M 0.24% 116
2018
Q4 		$21.7M Sell
174,743
-3,698
-2% -$549K 0.12% 167
2018
Q3 		$30M Sell
178,441
-2,139
-1% -$368K 0.14% 156
2018
Q2 		$31.1M Sell
180,580
-3,560
-2% -$582K 0.14% 156
2018
Q1 		$27.8M Buy
184,140
+1,847
+1% +$271K 0.13% 161
2017
Q4 		$24.5M Buy
182,293
+176,324
+2,954% +$24.5M 0.11% 173
2017
Q3 		$873K Hold
5,969
– – ﹤0.01% 488
2017
Q2 		$928K Buy
+5,969
New +$913K ﹤0.01% 497
2017
Q1 		– Sell
-9,651
Closed -$1.05M – 555
2016
Q4 		$1.05M Buy
+9,651
New +$1.07M ﹤0.01% 414
2016
Q2 		– Sell
-1,686
Closed -$220K – 507
2016
Q1 		$220K Hold
1,686
– – ﹤0.01% 471
2015
Q4 		$237K Buy
+1,686
New +$234K ﹤0.01% 504
2014
Q4 		– Sell
-2,500
Closed -$401K – 465
2014
Q3 		$401K Sell
2,500
-5,100
-67% -$784K ﹤0.01% 385
2014
Q2 		$1.12M Sell
7,600
-5,100
-40% -$707K ﹤0.01% 354
2014
Q1 		$1.76M Sell
12,700
-66,100
-84% -$9.95M 0.01% 305
2013
Q4 		$9.97M Buy
78,800
+14,300
+22% +$1.48M 0.04% 216
2013
Q3 		$5.93M Buy
+64,500
New +$5.2M 0.03% 264

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

AJO LP's JAZZ Position: Q1 2021 in Review

AJO LP sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2021, closing a stake of 3,833 shares — an estimated $632K sold.

AJO LP first reported a position in JAZZ in Q3 2013 and held it in 23 quarters. The position peaked at $69.2M in Q4 2019. 442 funds tracked by Wall St. Rank hold JAZZ as of Q1 2021.

  • AJO LP reported no remaining Jazz Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • AJO LP sold 3,833 Jazz Pharmaceuticals shares in Q1 2021, an estimated $632K.
  • AJO LP first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 23 quarters.
  • AJO LP's Jazz Pharmaceuticals position peaked at $69.2M in Q4 2019.
  • 442 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2021.

Based on AJO LP's 13F filing for Q1 2021, filed 7 May 2021.